Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingjin Pingchuan recipe is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of respiratory conditions, specifically severe community-acquired pneumonia (SCAP). The recipe is based on the TCM principles of clearing heat, resolving phlegm, and relieving asthma (Pingchuan). It is typically administered as an oral decoction or in granule form. Clinical research, primarily led by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, focuses on its ability to modulate the inflammatory response, improve oxygenation, and potentially reduce the duration of mechanical ventilation in critically ill patients. Like many TCM formulas, it is thought to exert its effects through a multi-component, multi-target mechanism involving the regulation of pro-inflammatory cytokines and the protection of lung tissue from oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingjin Pingchuan recipe.